Table 1.

Characteristics of the 5 children with FMF.

PatientSexMEFVDisease Duration, moAttacks/moAnti-TNF Duration, moAnti-IL-1 Duration, moAttacks/mo After Anti-IL-1 Therapy
1FM694V/M694V12040301*
2MM694V/M694V1084090
3FM680I/M680I842320
4MM680I/M694V724671*
5FM694V/M694V725690
  • * In those who continued to have one attack/mo (decreased from 4/mo) the duration and severity of fever and pain decreased significantly.